79 related articles for article (PubMed ID: 6226016)
1. [Hodgkin's disease: analysis of a reduction of chemotherapy].
Fermé C; Teillet F; D'Agay MF; Boiron M
Presse Med; 1983 Sep; 12(33):2031-4. PubMed ID: 6226016
[TBL] [Abstract][Full Text] [Related]
2. Combined modality in Hodgkin's disease. Comparison of six versus three courses of MOPP with clinical and surgical restaging.
Ferme C; Teillet F; d'Agay MF; Gisselbrecht C; Marty M; Boiron M
Cancer; 1984 Dec; 54(11):2324-9. PubMed ID: 6388801
[TBL] [Abstract][Full Text] [Related]
3. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
Cramer P; Andrieu JM
J Clin Oncol; 1985 Nov; 3(11):1495-502. PubMed ID: 3903063
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
[TBL] [Abstract][Full Text] [Related]
6. MOPP chemotherapy plus irradiation for Hodgkin's disease, stages IA to IIIB. Long-term results of the prospective trial H72 (1972-1976, 334 patients).
Andrieu JM; Dana M; Desprez-Curely JP; Jacquillat C; Weil M
Hematol Oncol; 1985; 3(4):219-31. PubMed ID: 3841333
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin's disease in children. Results of therapy in a mixed group of 178 clinical and pathologically staged patients over 13 years.
Bayle-Weisgerber C; Lemercier N; Teillet F; Asselain B; Gout M; Schweisguth O
Cancer; 1984 Jul; 54(2):215-22. PubMed ID: 6547073
[TBL] [Abstract][Full Text] [Related]
8. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
[No Abstract] [Full Text] [Related]
9. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML
J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease.
Andrieu JM; Ifrah N; Payen C; Fermanian J; Coscas Y; Flandrin G
J Clin Oncol; 1990 Jul; 8(7):1148-54. PubMed ID: 2193118
[TBL] [Abstract][Full Text] [Related]
11. Second malignant tumours in childhood Hodgkin's disease.
Jenkin D; Greenberg M; Fitzgerald A
Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
[TBL] [Abstract][Full Text] [Related]
12. Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.
Yelle L; Bergsagel D; Basco V; Brown T; Bush R; Gillies J; Israels L; Miller A; Rideout D; Whitelaw D
J Clin Oncol; 1991 Nov; 9(11):1983-93. PubMed ID: 1941057
[TBL] [Abstract][Full Text] [Related]
13. Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie.
Raemaekers J; Burgers M; Henry-Amar M; Pinna A; Mandard A; Monfardini S; Hagenbeek A; Breed W; Carde P; Vovk M; van Hoof A; Thomas J; Noordijk E
Ann Oncol; 1997; 8 Suppl 1():111-4. PubMed ID: 9187443
[TBL] [Abstract][Full Text] [Related]
14. [Comparative evaluation of the efficacy of chemotherapy and chemoradiotherapy of stage IIIB Hodgkin's disease].
Kanaev SV; Gershanovich ML; Malinin AP; Kholin AV
Vopr Onkol; 1988; 34(4):438-45. PubMed ID: 3376456
[TBL] [Abstract][Full Text] [Related]
15. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
16. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Canellos GP; Anderson JR; Propert KJ; Nissen N; Cooper MR; Henderson ES; Green MR; Gottlieb A; Peterson BA
N Engl J Med; 1992 Nov; 327(21):1478-84. PubMed ID: 1383821
[TBL] [Abstract][Full Text] [Related]
18. [Hodgkin's disease].
Ohtake S; Nakamura S
Rinsho Ketsueki; 1989 Aug; 30(8):1193-6. PubMed ID: 2601031
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease in children: treatment results with MOPP and low-dose, extended-field irradiation.
Jenkin D; Chan H; Freedman M; Greenberg M; Gribbin M; McClure P; Saunders F; Sonley M
Cancer Treat Rep; 1982 Apr; 66(4):949-59. PubMed ID: 7042093
[TBL] [Abstract][Full Text] [Related]
20. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]